Antares Pharma reported $11.54M in Stock for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Abbott ABT:US $ 5691M 534M
Abbvie ABBV:US $ 3483M 355M
Adma Biologics ADMA:US $ 139.15M 14.42M
Ani Pharmaceuticals ANIP:US $ 83.16M 1.46M
Becton, Dickinson and BDX:US $ 3258M 223M
Cara Therapeutics CARA:US 1.91M 677K
Cerus CERS:US $ 28.52M 1.73M
Eli Lilly And LLY:US $ 3893M 7M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Meridian Bioscience VIVO:US $ 70.93M 3.27M
Orasure Technologies OSUR:US $ 61.54M 8.4M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Pfizer PFE:US $ 9979M 920M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Staar Surgical STAA:US $ 18.45M 1.18M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Teva Pharmaceutical TEVA:IT 4.01B 194M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M